Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kura Oncology (KURA) Amortization of Deferred Charges: 2024-2025

Historic Amortization of Deferred Charges for Kura Oncology (KURA) over the last 2 years, with Sep 2025 value amounting to $141,000.

  • Kura Oncology's Amortization of Deferred Charges rose 5.22% to $141,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $552,000, marking a year-over-year change of. This contributed to the annual value of $523,000 for FY2024, which is 9.64% up from last year.
  • Kura Oncology's Amortization of Deferred Charges amounted to $141,000 in Q3 2025, which was up 2.17% from $138,000 recorded in Q2 2025.
  • In the past 5 years, Kura Oncology's Amortization of Deferred Charges ranged from a high of $141,000 in Q3 2025 and a low of $122,000 during Q1 2024.
  • For the 2-year period, Kura Oncology's Amortization of Deferred Charges averaged around $133,571, with its median value being $134,000 (2024).
  • Data for Kura Oncology's Amortization of Deferred Charges shows a peak YoY climbed of 9.02% (in 2025) over the last 5 years.
  • Kura Oncology's Amortization of Deferred Charges (Quarterly) stood at $140,000 in 2024, then grew by 5.22% to $141,000 in 2025.
  • Its Amortization of Deferred Charges was $141,000 in Q3 2025, compared to $138,000 in Q2 2025 and $133,000 in Q1 2025.